Phase 4 Trial Shows Opsumit Can Improve Ventricle Function for Pulmonary Arterial Hypertension Patients
source: pixabay.com

Phase 4 Trial Shows Opsumit Can Improve Ventricle Function for Pulmonary Arterial Hypertension Patients

A recent Phase 4 study has shown that Opsumit can improve function of the right heart ventricle for patients with pulmonary arterial hypertension (PAH). The right ventricle pumps blood to…

Continue Reading Phase 4 Trial Shows Opsumit Can Improve Ventricle Function for Pulmonary Arterial Hypertension Patients
How Rare Disease Biotech “Cure Rare Disease” Is Handling COVID-19
source: pixabay.com

How Rare Disease Biotech “Cure Rare Disease” Is Handling COVID-19

From social distancing and shuttered businesses to personal health concerns, COVID-19 has changed daily life for the foreseeable future. There are nearly 4.75 million diagnoses worldwide, with 1.53 million in…

Continue Reading How Rare Disease Biotech “Cure Rare Disease” Is Handling COVID-19
Gilead Donates 940,000 Remdesivir Doses
Photo by Paweł Czerwiński on Unsplash

Gilead Donates 940,000 Remdesivir Doses

Multiple biotechnology and pharmaceutical companies have joined in the fight against COVID-19. But one, Gilead Sciences, has been at the forefront of both progress and controversy. The company developed remdesivir,…

Continue Reading Gilead Donates 940,000 Remdesivir Doses

Doctors Report First Ever Successful Transplant of Reprogrammed Cells into the Brain of a Parkinson’s Patient

A recent article in US News and World Report gives an account of the first patient to have reprogrammed cells successfully implanted in his brain. The patient’s doctors reported that…

Continue Reading Doctors Report First Ever Successful Transplant of Reprogrammed Cells into the Brain of a Parkinson’s Patient
A Negative Side Effect of COVID-19: Reduced Cancer Screenings
Photo by National Cancer Institute on Unsplash

A Negative Side Effect of COVID-19: Reduced Cancer Screenings

In her early 20's, Mackenzie Alleman lost her mother to breast cancer. Then, at 28, she herself underwent a preventative double mastectomy after learning that she carried the mutated BRCA1 gene.…

Continue Reading A Negative Side Effect of COVID-19: Reduced Cancer Screenings
Exploring the Similar Pathology “Genetic Doppelgängers” ALS and SCA36
Thor_Deichmann / Pixabay

Exploring the Similar Pathology “Genetic Doppelgängers” ALS and SCA36

Recently, scientists from Emory University set out to discover whether there was any pathological link between spinocerebellar ataxia type 36 (SCA36) and amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD). Both…

Continue Reading Exploring the Similar Pathology “Genetic Doppelgängers” ALS and SCA36
Research Links Metabolic Syndrome in Parkinson’s Patients Who Have LRRK2 Mutations
source: pixabay.com

Research Links Metabolic Syndrome in Parkinson’s Patients Who Have LRRK2 Mutations

  A recent article in Parkinson’s News Today described new findings associated with mutations in the LRRK2 gene, which are associated with Parkinson’s disease (PD). Indications are that patients with…

Continue Reading Research Links Metabolic Syndrome in Parkinson’s Patients Who Have LRRK2 Mutations
Could Biobots be the Key to Understanding ALS and other Neuromuscular Diseases?
source: pixabay.com

Could Biobots be the Key to Understanding ALS and other Neuromuscular Diseases?

  Biological robots, commonly known as biobots, mimic the actions of other organisms (e.g. jumping or swimming). Biobots are composed of artificial materials and also organic material. As published in…

Continue Reading Could Biobots be the Key to Understanding ALS and other Neuromuscular Diseases?
Atypical Hemolytic Uremic Syndrome & Pregnancy: Early Diagnosis Means Better Outcomes
source: pixabay.com

Atypical Hemolytic Uremic Syndrome & Pregnancy: Early Diagnosis Means Better Outcomes

Atypical hemolytic uremic syndrome (aHUS) is a rare condition which can be sparked by pregnancy, although it can also occur without it. Essentially, if you are genetically predisposed to the condition,…

Continue Reading Atypical Hemolytic Uremic Syndrome & Pregnancy: Early Diagnosis Means Better Outcomes
Controls Needed for the Dupuytren Biomarker Discovery Pilot Study
source: pixabay.com

Controls Needed for the Dupuytren Biomarker Discovery Pilot Study

We need controls! No, not cockpit controls or videogame controls, and no, we're not out of control. We need control participants for the Dupuytren Biomarker Discovery Pilot Study. Our goal is…

Continue Reading Controls Needed for the Dupuytren Biomarker Discovery Pilot Study

Former UFC Athlete Joe Ellenberger’s Toughest Opponent: Paroxysmal Nocturnal Hemoglobinuria

The UFC has some tough fighters in it. But 35-year-old Joe Ellenberger never thought that his most difficult opponent would be within himself. That is, his paroxysmal nocturnal hemoglobinuria (PNH),…

Continue Reading Former UFC Athlete Joe Ellenberger’s Toughest Opponent: Paroxysmal Nocturnal Hemoglobinuria
Retevmo Approved for Treatment of Genetically-Mutated Lung and Thyroid Cancers
source: pixabay.com

Retevmo Approved for Treatment of Genetically-Mutated Lung and Thyroid Cancers

A recent BioSpace press release shares some exciting news for patients with non-small cell lung cancer, medullary thyroid cancer, and other thyroid cancers caused by RET gene mutations. Retevmo (selpercatinib) is the…

Continue Reading Retevmo Approved for Treatment of Genetically-Mutated Lung and Thyroid Cancers
UCSF Scientists Use Genes as an On/Off Switch to Fight Autoimmune Diseases and Cancer
source: pixabay.com

UCSF Scientists Use Genes as an On/Off Switch to Fight Autoimmune Diseases and Cancer

  Immunotherapies are in the forefront for treating autoimmune diseases and cancer. Northwestern University and the University of California San Francisco conducted a study using genes that have the potential…

Continue Reading UCSF Scientists Use Genes as an On/Off Switch to Fight Autoimmune Diseases and Cancer
UCSF Scientists Use Genes as an On/Off Switch to Fight Autoimmune Diseases and Cancer
source: pixabay.com

UCSF Scientists Use Genes as an On/Off Switch to Fight Autoimmune Diseases and Cancer

  Immunotherapies are in the forefront for treating autoimmune diseases and cancer. Northwestern University and the University of California San Francisco conducted a study using genes that have the potential…

Continue Reading UCSF Scientists Use Genes as an On/Off Switch to Fight Autoimmune Diseases and Cancer
Treatment for HATTR Amyloidosis Polyneuropathy Approved for Reimbursement in Spain
source: pixabay.com

Treatment for HATTR Amyloidosis Polyneuropathy Approved for Reimbursement in Spain

According to a story from Guru Focus, the biopharmaceutical company Akcea Therapeutics, Inc., an affiliate of Ionis Pharmaceuticals, Inc. recently announced that the Ministry of Health of Spain has cleared…

Continue Reading Treatment for HATTR Amyloidosis Polyneuropathy Approved for Reimbursement in Spain